To present current information on the diagnosis, pathogenesis, natural history, and treatment of infantile hemangiomas.
Methods
Literature review.
Results
Infantile hemangiomas are the most common vascular tumors of childhood. They are thought to be derived from embolized placental progenitor cells that lodge in privileged sites of the developing embryo. They exhibit a characteristic postnatal course with defined periods of growth and regression.
Conclusions
Multimodality intervention involving observation, medical therapy, laser photocoagulation, and surgery is the accepted modern approach. Timing of the intervention to obtain the best possible results in concert with developmental milestones is the goal. “Leave it alone—it will go away” is no longer universally acceptable advice for infantile hemangiomas.
Get full access to this article
View all access options for this article.
References
1.
EnjolrasO, MullikenJB. Vascular tumors and vascular malformations (new issues).. Adv Dermatol. 1997; 13:375–423 9551150
2.
HassaneinAH, MullikenJB, FishmanSJ, GreeneAK. Evaluation of terminology for vascular anomalies in current literature.. Plast Reconstr Surg. 2011; 127(1):347–351 21200229
3.
MarlerJJ, MullikenJB. Vascular anomalies: classification, diagnosis, and natural history.. Facial Plast Surg Clin North Am. 2001; 9(4):495–504 17590938
4.
DroletBA, SwansonEA, FriedenIJ. Hemangioma Investigator Group. Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants.. J Pediatr. 2008; 153(5):712–715, 715, e1 18940356
5.
ChillerKG, PassaroD, FriedenIJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex.. Arch Dermatol. 2002; 138(12):1567–1576 12472344
6.
WanerM, NorthPE, SchererKA, FriedenIJ, WanerA, MihmMCJr. The nonrandom distribution of facial hemangiomas.. Arch Dermatol. 2003; 139(7):869–875 12873881
7.
HaggstromAN, DroletBA, BaselgaE, et al.. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment.. Pediatrics. 2006; 118(3):882–887 16950977
NorthPE, WanerM, MizerackiA, et al.. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta.. Arch Dermatol. 2001; 137(5):559–570 11346333
10.
BarnésCM, Christison-LagayEA, FolkmanJ. The placenta theory and the origin of infantile hemangioma.. Lymphat Res Biol. 2007; 5(4):245–255 18370915
11.
KhanZA, BoscoloE, PicardA, et al.. Multipotential stem cells recapitulate human infantile hemangiomas in immunodefficient mice.. J Clin Invest. 2008; 118(7):2592–2599
12.
HuangSA, TuHM, HarneyJW, et al.. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas.. N Engl J Med. 2000; 343(3):185–189 10900278
13.
EnjolrasO, WassefM, MazoyerE, et al.. Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas.. J Pediatr. 1997; 130(4):631–640 9108863
14.
FinnMC, GlowackiJ, MullikenJB. Congenital vascular lesions: clinical application of a new classification.. J Pediatr Surg. 1983; 18(6):894–900 6663421
15.
WilliamsEFIII, HochmanM, RodgersBJ, BrockbankD, ShannonL, LamSM. A psychological profile of children with hemangiomas and their families.. Arch Facial Plast Surg. 2003; 5(3):229–234 12756116
16.
BatnijiRK, BuckinghamED, WilliamsEFIII. An aesthetic approach to facial hemangiomas.. Arch Facial Plast Surg. 2005; 7(5):301–306 16172337
17.
BurnsAJ, NavarroJA, CoonerRD. Classification of vascular anomalies and the comprehensive treatment of hemangiomas.. Plast Reconstr Surg. 2009; 124(1)(suppl):69e–81e 19568141
18.
BurnsAJ, NavarroJA. Role of laser therapy in pediatric patients.. Plast Reconstr Surg. 2009; 124(1)(suppl):82e–92e 19568142
19.
BattaK, GoodyearHM, MossC, WilliamsHC, HillerL, WatersR. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis.. Lancet. 2002; 360(9332):521–527 12241656
20.
ThomasRF, HornungRL, ManningSC, PerkinsJA. Hemangiomas of infancy: treatment of ulceration in the head and neck.. Arch Facial Plast Surg. 2005; 7(5):312–315 16172339
21.
AdamsDM. The nonsurgical management of vascular lesions.. Facial Plast Surg Clin North Am. 2001; 9(4):601–608 17590946
22.
BennettML, FleischerABJr, ChamlinSL, FriedenIJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation.. Arch Dermatol. 2001; 137(9):1208–1213 11559219
23.
GreenbergerS, BoscoloE, AdiniI, MullikenJB, BischoffJ. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells.. N Engl J Med. 2010; 362(11):1005–1013 20237346
24.
BoonLM, MacDonaldDM, MullikenJB. Complications of systemic corticosteroid therapy for problematic hemangioma.. Plast Reconstr Surg. 1999; 104(6):1616–1623 10541160
25.
PeridisS, PilgrimG, AthanasopoulosI, ParpounasK. A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas [published online February 16, 2011].. Int J Pediatr Otorhinolaryngol. doi:10.1016/j.ijporl.2011.01.028 21333364
26.
StorchCH, HoegerPH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action.. Br J Dermatol. 2010; 163(2):269–274 20456345
27.
ZvulunovA, McCuaigC, FriedenIJ. Oral propranolol therapy for infantile hemangiomas beyond the proliferative phase: a multicenter retrospective study.. Pediatr Dermatol. 2011; 10(1111):1525–1470
28.
HochmanM, WilliamsEFIII. Management of cutaneous hemangiomas.. Facial Plast Surg Clin North Am. 2001; 9(4):621–628 17590948
29.
KulbershJ, HochmanM. Serial excision of facial hemangiomas.. Arch Facial Plast Surg. 2011; 13(3):199–202
30.
WanerM, KastenbaumJ, SchererK. Hemangiomas of the nose: surgical management using a modified subunit approach.. Arch Facial Plast Surg. 2008; 10(5):329–334 18794411
